Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug

Go back to Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
DR. REDDY'S LAB LTD ADR (NYSE: RDY) Delayed: 12.18 --0 (-0%)
Previous Close $12.18    52 Week High $54.73 
Open $12.18    52 Week Low $40.68 
Day High $12.18    P/E N/A 
Day Low $12.18    EPS $0.00 
Volume 8,770